Ian Botham
Tracked across 4 events · 25 articles · First seen Apr 09, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Ian Botham, CEO of ZEO ScientifiX, is a key spokesperson for the event, emphasizing the company's commitment to education. His involvement highlights leadership support but does not directly affect the company's financials.
Aug 04, 2026 · 6 articles
Business
Impact: As CEO, Ian Botham provides strategic leadership and public endorsement of the event, reinforcing the company's commitment to physician education.
Sep 01, 2026 · 6 articles
Business
Impact: Ian Botham, CEO of ZEO ScientifiX, expressed that the collaboration validates ZEO ScientifiX's commitment to research and provides an opportunity to play a central role in the U.S. regenerative medicine market.
Apr 09, 2026 · 7 articles
Business
ZEO ScientifiX, Inc. (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on regenerative biologics, announced on September 15, 2026 its planned expansion into Georgia and United States — Tennessee. The move follows the recent enactment of state…
Impact: CEO Ian Botham is quoted describing the Georgia and United States — Tennessee expansion as a next step in building a scalable national regenerative medicine platform.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Ian Botham live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard